258 related articles for article (PubMed ID: 28207778)
1. Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-Impact for mortality.
Woitas RP; Scharnagl H; Kleber ME; Delgado GE; Grammer TB; Pichler M; Krämer BK; März W; Stojakovic T
PLoS One; 2017; 12(2):e0171574. PubMed ID: 28207778
[TBL] [Abstract][Full Text] [Related]
2. Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Lindberg S; Pedersen SH; Mogelvang R; Jensen JS; Flyvbjerg A; Galatius S; Magnusson NE
J Am Coll Cardiol; 2012 Jul; 60(4):339-45. PubMed ID: 22813613
[TBL] [Abstract][Full Text] [Related]
3. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men.
Helmersson-Karlqvist J; Larsson A; Carlsson AC; Venge P; Sundström J; Ingelsson E; Lind L; Arnlöv J
Atherosclerosis; 2013 Apr; 227(2):408-13. PubMed ID: 23375682
[TBL] [Abstract][Full Text] [Related]
4. Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndrome.
Nymo SH; Hartford M; Ueland T; Yndestad A; Lorentzen E; Truvé K; Karlsson T; Ravn-Fischer A; Aukrust P; Caidahl K
Int J Cardiol; 2018 Jul; 262():79-84. PubMed ID: 29622507
[TBL] [Abstract][Full Text] [Related]
5. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease.
Katagiri M; Takahashi M; Doi K; Myojo M; Kiyosue A; Ando J; Hirata Y; Komuro I
Heart Vessels; 2016 Oct; 31(10):1595-602. PubMed ID: 26614309
[TBL] [Abstract][Full Text] [Related]
6. Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study.
Kunutsor SK; Flores-Guerrero JL; Kieneker LM; Nilsen T; Hidden C; Sundrehagen E; Seidu S; Dullaart RPF; Bakker SJL
Clin Chim Acta; 2018 Nov; 486():66-75. PubMed ID: 30036522
[TBL] [Abstract][Full Text] [Related]
7. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil gelatinase-associated lipocalin (NGAL) and cardiovascular events in patients with stable coronary artery disease.
Sivalingam Z; Erik Magnusson N; Grove EL; Hvas AM; Dalby Kristensen S; Bøjet Larsen S
Scand J Clin Lab Invest; 2018 Oct; 78(6):470-476. PubMed ID: 30261750
[TBL] [Abstract][Full Text] [Related]
9. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.
Alderson HV; Ritchie JP; Pagano S; Middleton RJ; Pruijm M; Vuilleumier N; Kalra PA
Clin J Am Soc Nephrol; 2016 Dec; 11(12):2141-2149. PubMed ID: 27852662
[TBL] [Abstract][Full Text] [Related]
10. Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease.
Hasegawa M; Ishii J; Kitagawa F; Takahashi K; Hayashi H; Koide S; Tomita M; Takahashi H; Ozaki Y; Yuzawa Y
Heart Vessels; 2015 Jan; 30(1):81-8. PubMed ID: 24378882
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
12. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
[TBL] [Abstract][Full Text] [Related]
13. Association Between Plasma Neutrophil Gelatinase-Associated Lipocalin and Cardiac Disease Hospitalizations and Deaths in Older Women.
Chong JJH; Prince RL; Thompson PL; Thavapalachandran S; Ooi E; Devine A; Lim EEM; Byrnes E; Wong G; Lim WH; Lewis JR
J Am Heart Assoc; 2019 Jan; 8(1):e011028. PubMed ID: 30595080
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of neutrophil gelatinase-associated lipocalin and glycosylated hemoglobin for non-ST-segment elevation myocardial infarction patients with single concomitant chronic total occlusion following primary percutaneous coronary intervention: A prospective observational study.
Peng W; Zhang C; Wang Z; Yang W; Luo H; Li X; Fu D; Yu C; Zhou Y
Medicine (Baltimore); 2019 Sep; 98(39):e16982. PubMed ID: 31574797
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
[TBL] [Abstract][Full Text] [Related]
16. Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis.
Lindberg S; Jensen JS; Mogelvang R; Pedersen SH; Galatius S; Flyvbjerg A; Magnusson NE
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2135-42. PubMed ID: 24969771
[TBL] [Abstract][Full Text] [Related]
17. Serial measurements of neutrophil gelatinase-associated lipocalin: prognostic value in patients with ST-segment elevation myocardial infarction treated with a primary percutaneous coronary intervention.
Lim YM; Moon JY; Min D; Kim SH; Yang WI; Kim WJ; Sung JH; Kim IJ; Lim SW; Cha DH
Coron Artery Dis; 2017 Dec; 28(8):690-696. PubMed ID: 28737526
[TBL] [Abstract][Full Text] [Related]
18. Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.
Daniels LB; Barrett-Connor E; Clopton P; Laughlin GA; Ix JH; Maisel AS
J Am Coll Cardiol; 2012 Mar; 59(12):1101-9. PubMed ID: 22421304
[TBL] [Abstract][Full Text] [Related]
19. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease.
Sahinarslan A; Kocaman SA; Bas D; Akyel A; Ercin U; Zengin O; Timurkaynak T
Coron Artery Dis; 2011 Aug; 22(5):333-8. PubMed ID: 21558855
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of plasma neutrophil gelatinase-associated lipocalin in patients with heart failure.
Villacorta H; Santos RA; Marroig MA; Pereira GP; Xavier AR; Kanaan S
Rev Port Cardiol; 2015; 34(7-8):473-8. PubMed ID: 26162288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
